SecuraBio
Pre-Approval PRO BETASlowing Activity
No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 5/19/2025
Pipeline by Phase
Therapeutic Focus
Clinical Trials (23)
A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype
Started: 5/19/2025
Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma
Started: 9/1/2014
A Phase 3 Extension Study of Duvelisib and Ofatumumab in Participants With CLL/SLL Previously Enrolled in Study IPI-145-07
Started: 12/1/2013
A Phase 3 Study of Duvelisib Versus Ofatumumab in Patients With Relapsed or Refractory CLL/SLL (DUO)
Started: 11/1/2013
A Study of Duvelisib in Combination With Rituximab and Bendamustine vs Placebo in Combination With Rituximab and Bendamustine in Subjects With Previously-Treated Indolent Non-Hodgkin Lymphoma (BRAVURA)
Started: 12/1/2015
A Study of Duvelisib in Participants With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Started: 2/22/2018
A Phase 2 Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Participants With Indolent Non-Hodgkin Lymphoma
Started: 9/24/2019
A Long-term, Continued Treatment and Follow-up Study in Participants With Hematologic Malignancies Treated With Duvelisib (IPI-145)
Started: 4/1/2016
A Study of Duvelisib in Participants With Refractory Indolent Non-Hodgkin Lymphoma
Started: 6/17/2013
Phase 2 Study of Duvelisib in Previously Treated Patients With Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma
Started: 2/12/2018
Duvelisib With Rituximab vs R-CHOP in Subjects With Relapsed/Refractory Follicular Lymphoma (FRESCO)
Started: 12/1/2015
A Double-Blind Study Evaluating Duvelisib in Subjects With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone
Started: 4/1/2013
A Phase 2a, Efficacy and Safety Study of Duvelisib in Mild Asthmatic Subjects
Started: 7/1/2012
A Study of Duvelisib in Combination With Rituximab or Obinutuzumab in Subjects With Previously Untreated CD20+ Follicular Lymphoma (CONTEMPO)
Started: 12/1/2014
A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck Cancer
Started: 6/1/2020
Duvelisib With Obinutuzumab in Patients With CLL/SLL Previously Treated With a BTKi (SYNCHRONY)
Started: 2/1/2015
IPI-145 Single Ascending, Multiple Ascending, Food Effect and Drug-Drug-Interaction Study
Started: 8/1/2011
Phase 1 Study in Healthy Subjects to Evaluate the Effect of IPI-145 on the Pharmacokinetics of Midazolam
Started: 8/1/2013
A Phase 1 Study of Duvelisib in Patients With Advanced Hematologic Malignancies
Started: 10/1/2011
Phase 1 Study in Healthy Subjects to Evaluate the Effect of Rifampin on the Pharmacokinetics of IPI-145
Started: 10/1/2013
Duvelisib in Hepatically Impaired Subjects Compared to Healthy Subjects
Started: 3/1/2014
Bioequivalence of Duvelisib and Food Effect on Pharmacokinetics of IPI-145
Started: 11/1/2014